"Non-target embolization is a frequently under-diagnosed, sometimes fatal, problem that interventional radiologists encounter every time they work with embolics” said Irene Bargellini at the first Embolotherapy conference.
The SeQure® Family gathers physicians who share their experience or want to learn from their peers.
Today, we propose a case report by Dr Pav Najran on Y90 embolization with SeQure XSB.
Join the SeQure® Family
By joining the family today, you will also receive early access to the recording of our upcoming symposium "Beyond access, does the catheter choice influence procedure success?" with Drs. Ron Gaba, Youssef Zaarour and Sachin Modi.
Please leave your details in the form.
SeQure® is an innovative reflux control microcatheter, designed to deliver more targeted treatment and use a wide range of beads, from extra-small to large.
Sequre® microcatheters are class IIb medical devices intended for use by interventional radiologists and interventional oncologists for the infusion of contrast media into all peripheral vessels and for drug infusion in intra-arterial therapy, and infusion of embolic materials. They should not be used in cerebral vessels. For complete information about precautions and optimal usage conditions for these medical devices, we recommend consulting the instructions for use supplied with each device or with your local Guerbet representative(s). Information for use only in countries with applicable health authority registrations. Notified Body: MedCert 0482. Manufacturer: Accurate Medical Therapeutics Ltd. EC Rep: Guerbet. Document creation date: September 2019. Sequre® is a registered trademark of Guerbet Group or its affiliates.